Momentis Surgical™ Ltd, a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida Northwest Hospital has acquired the Anovo™ Surgical System for use in transvaginal benign gynecological procedures including hysterectomies. The Anovo System is the first and only FDA-authorized surgical robot with features including shoulder, elbow, and wrist joints designed to mimic human arms and provide human level dexterity.
“It is essential for surgeons to use the most advanced tools and technologies to ensure we deliver optimal care to our patients, and this system presents several advantages compared to other available robotic technologies,” said Daniel Gomez, MD, FACOG, FACS, a minimally invasive gynecologic surgeon and assistant program director of the OBGYN Residency Program at HCA Florida Northwest Hospital. “By enabling the transvaginal approach to benign gynecological procedures including benign hysterectomies, we can perform minimally invasive surgery that may deliver benefits including less pain after surgery, leading to a faster recovery, and virtually no visible scarring. We are also excited to train the next generation of gynecologic surgeons on this new platform to further advance the surgical care that our current OBGYN residents will provide to their patients in the future.”
The Anovo System was granted de novo marketing authorization from the U.S. Food and Drug Administration (FDA) in February 2021 for use in single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures including benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal. Multiple instruments can be introduced to the body through a single portal and the unprecedented articulation offers optimal access and working angles. Anovo is designed to enable surgeons to use the transvaginal approach in gynecological procedures, which has been well documented in clinical research as providing benefits including less patient pain and scarring, shorter recovery times and reduced infection rates, compared to other approaches.i In addition, the Anovo System requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery.
“We are pleased to have growing support from leading medical facilities in Florida including HCA Florida Northwest Hospital and hope to continue our momentum as we work to build broader commercial adoption of the Anovo System,” said Dvir Cohen, CEO and Co-Founder of Momentis. “We are dedicated to making this innovative technology available to more women and improving their surgical experience as well as that of the surgeons.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Biospace
